Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study

NCT06666010 is registered in ClinicalTrials.gov with Filament Health Corp. as lead sponsor.

NCT NCT06666010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06666010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study
Lead sponsor
Filament Health Corp.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 31, 2025
Completion date
July 31, 2028
Enrollment
86 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stimulant use disorder